Your browser doesn't support javascript.
loading
Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
Zhavoronkov, Alex; Vanhaelen, Quentin; Oprea, Tudor I.
Afiliação
  • Zhavoronkov A; Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Hong Kong, Hong Kong.
  • Vanhaelen Q; Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Hong Kong, Hong Kong.
  • Oprea TI; Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Clin Pharmacol Ther ; 107(4): 780-785, 2020 04.
Article em En | MEDLINE | ID: mdl-31957003
As the field of artificial intelligence and machine learning (AI/ML) for drug discovery is rapidly advancing, we address the question "What is the impact of recent AI/ML trends in the area of Clinical Pharmacology?" We address difficulties and AI/ML developments for target identification, their use in generative chemistry for small molecule drug discovery, and the potential role of AI/ML in clinical trial outcome evaluation. We briefly discuss current trends in the use of AI/ML in health care and the impact of AI/ML context of the daily practice of clinical pharmacologists.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacologia Clínica / Inteligência Artificial / Descoberta de Drogas Limite: Animals / Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacologia Clínica / Inteligência Artificial / Descoberta de Drogas Limite: Animals / Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2020 Tipo de documento: Article